TIBER CREEK GROUP for PHRMA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to the United States-Mexico-Canada-Agreement (USMCA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| LINDSEY LEDWIN | — |
Copyright/Patent/Trademark CPT
S. 1416 - Affordable Prescriptions for Patients Act of 2019. S. ___ No Combination Drug Patents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| TIMOTHY A MOLINO | — |
| JENNIFER OLSON | — |
Health Issues HCR
Issues related to pharmaceutical drug pricing and transparency. S. 474 SPIKE Act of 2019. S.476 C-THRU Act of 2019. Issues related to the illegal importation of prescription drugs. Issues related to capping out of pocket costs. S.475 Rx Cap Act of 2019. S.62 Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Medicare/Medicaid MMM
Issues related to Medicare Part B pricing reform. Issues related to Medicare Part D pricing reform. Proposal to eliminate Medicaid inflationary cap
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.